Primary cutaneous γδ-T-cell lymphoma treated with low-dose methotrexate and narrowband ultraviolet B irradiation: Report of a case with testicular involvement

Journal of Dermatology

Volumn 38, Issue 4, 2011, Pages 368-372

  Fujii, Mizue ^a   Uehara, Jiro ^a   Honma, Masaru ^a   Ito, Yasuhiro ^a   Takahashi, Hidetoshi ^a   Ishida Yamamoto, Akemi ^a   Iizuka, Hajime ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

methotrexate; primary cutaneous T cell lymphoma; testicular involvement; ultraviolet B

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GLUCOCORTICOID; METHOTREXATE; PERFORIN; PROTEIN TCR BETAF1; PROTEIN TIA 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; CUTANEOUS T CELL LYMPHOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LOW DRUG DOSE; MALE; PANNICULITIS; SKIN MANIFESTATION; TESTIS; TUMOR CELL; ULTRAVIOLET B RADIATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; METHOTREXATE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SKIN NEOPLASMS; TESTICULAR NEOPLASMS; ULTRAVIOLET THERAPY;

EID: 79953085405     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00998.x     Document Type: Article

References (20)

1. Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998; 91: 1723-1731. (Pubitemid 28110338)
2. Toro JR, Liewehr DJ, Pabby N, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood 2003; 101: 3407-3412. (Pubitemid 36857921)
3. Morelli L, Piscioli I, Licci S, Del Nonno F, Neri M, Sabattini E,. T/natural killer-cell lymphoma of the testis with cutaneous and subcutaneous soft tissue involvement: a management problem. Ann Hematol 2007; 86: 469-470. (Pubitemid 46630069)
4. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994.
5. Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004; 103: 2474-2479. (Pubitemid 38392996)
6. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R,. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol 1999; 155: 483-492. (Pubitemid 29370398)
7. Marzano AV, Ghislanzoni M, Gianelli U, Caputo R, Alessi E, Berti E,. Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement. Dermatology 2005; 211: 281-285. (Pubitemid 41415871)
8. Chan JK, Tsang WY, Lau WH, et al. Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer 1996; 77: 1198-1205. (Pubitemid 26080914)
9. Jung JT, Kim DH, Kwak EK, et al. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas. Ann Hematol 2006; 85: 575-581. (Pubitemid 44283077)
10. Gjerdrum LM, Woetmann A, Odum N, et al. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 2007; 21: 2512-2518. (Pubitemid 350148895)
11. Hosler GA, Liégeois N, Anhalt GJ, Moresi JM,. Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior. J Cutan Pathol 2008; 35: 1063-1067.
12. Marquard L, Poulsen CB, Gjerdrum LM, et al. Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas. Histopathology 2009; 54: 688-698.
13. Heald P, Buckley P, Gilliam A, et al. Correlations of unique clinical, immunotypic, and histologic findings in cutaneous gamma/delta T-cell lymphoma. J Am Acad Dermatol 1992; 26: 865-870.
14. Nakashima H, Sugaya M, Minatani Y, et al. Cutaneous gamma/delta T-cell lymphoma treated with retinoid and narrowband ultraviolet B. Clin Exp Dermatol 2009; 34: e345-e346.
15. Munn SE, McGregor JM, Jones A, et al. Clinical and pathological heterogeneity in cutaneous gamma-delta T-cell lymphoma: a report of three cases and a review of the literature. Br J Dermatol 1996; 135: 976-981. (Pubitemid 26397931)
16. Berti E, Cerri A, Cavicchini S, et al. Primary cutaneous gamma/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis. J Invest Dermatol 1991; 96: 718-723.
17. Vidulich K, Jones D, Duvic M,. Cutaneous gamma/delta T-cell lymphoma treated with radiation and denileukin diftitox. Clin Lymphoma Myeloma 2008; 8: 55-58. (Pubitemid 351449720)
18. Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 95: 3653-3661. (Pubitemid 30412833)
19. Zackheim HS, Kashani-Sabet M, McMillan A,. Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients. J Am Acad Dermatol 2003; 49: 873-878. (Pubitemid 37314876)
20. Zackheim HS, Kashani-Sabet M, Hwang ST,. Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients. J Am Acad Dermatol 1996; 34: 626-631. (Pubitemid 26098012)